BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zou M, Li D, Li L, Wu L, Sun C. Role of the endocannabinoid system in neurological disorders. Int J Dev Neurosci 2019;76:95-102. [PMID: 30858029 DOI: 10.1016/j.ijdevneu.2019.03.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Lowe H, Toyang N, Steele B, Bryant J, Ngwa W, Nedamat K. The Current and Potential Application of Medicinal Cannabis Products in Dentistry. Dent J (Basel) 2021;9:106. [PMID: 34562980 DOI: 10.3390/dj9090106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Fyke W, Velinov M. FMR1 and Autism, an Intriguing Connection Revisited. Genes (Basel) 2021;12:1218. [PMID: 34440392 DOI: 10.3390/genes12081218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
3 Dos Reis Rosa Franco G, Smid S, Viegas C. Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases. Curr Neuropharmacol 2021;19:449-64. [PMID: 32691712 DOI: 10.2174/1570159X18666200720172624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Joshi N, Onaivi ES. Psychiatric Disorders and Cannabinoid Receptors. Adv Exp Med Biol 2021;1264:131-53. [PMID: 33332008 DOI: 10.1007/978-3-030-57369-0_9] [Reference Citation Analysis]
5 Zou M, Liu Y, Xie S, Wang L, Li D, Li L, Wang F, Zhang Y, Xia W, Sun C, Wu L. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. Open Biol 2021;11:200306. [PMID: 33529552 DOI: 10.1098/rsob.200306] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
6 Demesa J, Appendino G, Morello G, Murray M, Muñoz E. The endocannabinoid system as a target for the treatment of neurological disorders. Neurotherapeutics in the Era of Translational Medicine 2021. [DOI: 10.1016/b978-0-12-816475-4.00002-1] [Reference Citation Analysis]
7 D'Elia A, Schiavi S, Soluri A, Massari R, Soluri A, Trezza V. Role of Nuclear Imaging to Understand the Neural Substrates of Brain Disorders in Laboratory Animals: Current Status and Future Prospects. Front Behav Neurosci 2020;14:596509. [PMID: 33362486 DOI: 10.3389/fnbeh.2020.596509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Greco R, Demartini C, Zanaboni AM, Tumelero E, Icco R, Sances G, Allena M, Tassorelli C. Peripheral changes of endocannabinoid system components in episodic and chronic migraine patients: A pilot study. Cephalalgia 2021;41:185-96. [PMID: 32967434 DOI: 10.1177/0333102420949201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
9 Ponton JA, Smyth K, Soumbasis E, Llanos SA, Lewis M, Meerholz WA, Tanguay RL. A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report. J Med Case Rep 2020;14:162. [PMID: 32958062 DOI: 10.1186/s13256-020-02478-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]